| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.39B | +10.7% |
| Cost of Revenue | $448.2M | +17.2% |
| Gross Profit | $939.9M | +7.9% |
| R&D Expense | $185.8M | +1.8% |
| SG&A Expense | $548.8M | +4.3% |
| Operating Income | $199.4M | +54.5% |
| Pre-tax Income | -$220.8M | -350.0% |
| Income Tax | $21.6M | -13.6% |
| Net Income | -$242.5M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $635.6M | +48.2% |
| Accounts Receivable | $216.0M | +11.8% |
| Inventory | $164.7M | +11.6% |
| Current Assets | $1.10B | -2.3% |
| Total Assets | $2.61B | +4.0% |
| Current Liabilities | $808.1M | +106.1% |
| Long-term Debt | $376.1M | -40.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $254.3M | +39.0% |
| Capital Expenditures | $81.0M | +72.1% |
| Investing Cash Flow | -$72.9M | -51.4% |
| Financing Cash Flow | -$285.7M | -1639.9% |
| Free Cash Flow | $173.3M | +27.5% |
| -483.5% |
| EPS (Basic) | -$4.45 | -480.3% |
| EPS (Diluted) | -$4.45 | -483.6% |
| Total Liabilities |
| $1.41B |
| +18.5% |
| Stockholders' Equity | $1.20B | -9.1% |